🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
The objective of this study is to establish the tipranavir-ritonavir steady...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02251132
Study to characterize the effects of two dose combinations of Tipranavir (T...
Status
Terminated
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT02245438
The objective of this study was to characterize the effect of two dose comb...
Status
Completed
Location
Multiple Locations
Start Date
2001-11
Trial ID
NCT02249416
Treatments Being Tested
To determine the effect of steady-state tipranavir 500 mg/ritonavir 200 mg ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT02229760
Treatments Being Tested
The aim of this trial is to evaluate the safety and virological and immunol...
Status
Completed
Location
Boehringer Ingelheim Investigational site 9
Start Date
2009-09
Trial ID
NCT00976950
Treatments Being Tested
This study was designed to provide early access to and evaluate the safety ...
Status
Approved For Marketing
Location
1182.70.127 Health Services Center, Inc.
Start Date
2004-12
Trial ID
NCT00097799
Treatments Being Tested
This study evaluated the safety and tolerability of tipranavir to improve t...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-05
Trial ID
NCT00144287
Treatments Being Tested
Study to characterise the effects of two dose combinations of tipranavir/ri...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT02251145
The objective of this study was to characterize the effects of two dose com...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT02253823
Treatments Being Tested